Effects of first-pass metabolism on metabolite mean residence time determination after oral administration of parent drug
- PMID: 2300537
- DOI: 10.1023/a:1015887626171
Effects of first-pass metabolism on metabolite mean residence time determination after oral administration of parent drug
Abstract
Metabolite kinetics after oral drug administration can be determined, without separate metabolite administration, using the concepts of mean residence time (MRT). The MRT of parent drug and metabolite after oral administration of the parent drug, MRTp,p(oral) and MRTm,p(oral), can be calculated directly from the drug and metabolite profiles. The difference between MRTm,p(oral) and MRTp,p(oral), termed Delta MRT, yields an estimate of MRT of metabolite when the metabolite is given as an iv bolus, MRTm,m(iv). The calculation is simple for drugs that are known to undergo, negligible first-pass metabolism. Correction can also be made when extent of first-pass metabolism is known. Ambiguity is encountered, however, when the degree of first-pass metabolism is unknown. When the delta MRT is negative, then first-pass metabolism must be considered. A positive value of delta MRT, on the other hand, is not a definitive indication of the absence of first-pass metabolism. It may occur in the presence or absence of first-pass metabolism. Ignoring the possibility of first-pass metabolism when a positive value of delta MRT occurs may lead to an incorrect estimate of MRTm,m(iv). The estimation error is relatively small, however, when MRTm,m(iv) much greater than MRTp,p(iv), even when first-pass metabolism is extensive. This situation may apply to the administration of a prodrug.
Similar articles
-
Mean residence time of oral drugs undergoing first-pass and linear reversible metabolism.Pharm Res. 1993 Jan;10(1):8-13. doi: 10.1023/a:1018904509178. Pharm Res. 1993. PMID: 8430064 Review.
-
A general model of metabolite kinetics following intravenous and oral administration of the parent drug.Biopharm Drug Dispos. 1988 Mar-Apr;9(2):159-76. doi: 10.1002/bod.2510090205. Biopharm Drug Dispos. 1988. PMID: 3370305
-
The role of metabolites in bioequivalency assessment. II. Drugs with linear pharmacokinetics and first-pass effect.Pharm Res. 1995 May;12(5):700-8. doi: 10.1023/a:1016259509257. Pharm Res. 1995. PMID: 7479556
-
A method for calculating the mean absorption time of drugs undergoing reversible and first-pass metabolism.Biopharm Drug Dispos. 1993 Jan;14(1):71-9. doi: 10.1002/bdd.2510140107. Biopharm Drug Dispos. 1993. PMID: 8427946
-
First-pass elimination. Basic concepts and clinical consequences.Clin Pharmacokinet. 1984 Jan-Feb;9(1):1-25. doi: 10.2165/00003088-198409010-00001. Clin Pharmacokinet. 1984. PMID: 6362950 Review.
Cited by
-
Site-differential gastrointestinal absorption of benazepril hydrochloride in healthy volunteers.Pharm Res. 1994 Mar;11(3):432-7. doi: 10.1023/a:1018925407109. Pharm Res. 1994. PMID: 8008712 Clinical Trial.
-
Mean residence time of oral drugs undergoing first-pass and linear reversible metabolism.Pharm Res. 1993 Jan;10(1):8-13. doi: 10.1023/a:1018904509178. Pharm Res. 1993. PMID: 8430064 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical